<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">urmj</journal-id><journal-title-group><journal-title xml:lang="ru">Уральский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Ural Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2949-4389</issn><publisher><publisher-name>Ural State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52420/umj.23.5.89</article-id><article-id custom-type="edn" pub-id-type="custom">QEHVCY</article-id><article-id custom-type="elpub" pub-id-type="custom">urmj-1609</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные статьи | Original articles</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original articles</subject></subj-group></article-categories><title-group><article-title>Динамика свободнорадикальных окислительных процессов в латентный период экспериментального метастазирования в печень</article-title><trans-title-group xml:lang="en"><trans-title>Dynamics of Free Radical Oxidative Processes During the Latent Period of Experimental Metastasizing to the Liver</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3618-6890</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Франциянц</surname><given-names>Е. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Frantsiyants</surname><given-names>E. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Елена Михайловна Франциянц — доктор биологических наук, профессор, заместитель генерального директора по науке</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Elena М. Frantsiyants - Doctor of Sciences (Biology), Professor, Deputy General Director for Science</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">super.gormon@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4318-7587</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сурикова</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Surikova</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Екатерина Игоревна Сурикова — кандидат биологических наук, старший научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Ekaterina I. Surikova - Candidate of Sciences (Biology), Senior Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">sunsur2000@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3972-2452</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каплиева</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaplieva</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Викторовна Каплиева — доктор медицинских наук, заведующий лабораторией изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Irina V. Kaplieva - Doctor of Sciences (Medicine), Head of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">kaplirina@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7395-3086</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нескубина</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neskubina</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ирина Валерьевна Нескубина — доктор биологических наук, старший научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на-Дону</p></bio><bio xml:lang="en"><p>Irina V. Neskubina - Doctor of Sciences (Biology), Senior Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">neskubina.irina@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3589-2115</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шакарян</surname><given-names>Э. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Shakaryan</surname><given-names>E. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Элионора Григорьевна Шакарян — аспирант кафедры онкологии</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Elionora G. Shakaryan - Postgraduate Student of the Department of Oncology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">elionora.shakaryan@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3998-8004</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Снежко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Snezhko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Александр Владимирович Снежко — доктор медицинских наук, хирург отделения абдоминальной онкологии № 1; ассистент кафедры онкологии</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Alexander V. Snezhko - Doctor of Sciences (Medicine), Surgeon of the Department of Abdominal Oncology No. 1; Assistant of the Department of Oncology</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">snezhko.tanya@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2302-8271</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бандовкина</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Bandovkina</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Валерия Ахтямовна Бандовкина — доктор биологических наук, ведущий научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Valeria A. Bandovkina - Doctor of Sciences (Biology), Leading Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">valerryana@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9749-2747</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Трепитаки</surname><given-names>Л. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Trepitaki</surname><given-names>L. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лидия Константиновна Трепитаки — кандидат биологических наук, научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Lidia K. Trepitaki - Candidate of Sciences (Biology), Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">legolab69@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2674-9832</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Погорелова</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Pogorelova</surname><given-names>Yu. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Юлия Александровна Погорелова — кандидат биологических наук, старший научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на-Дону</p></bio><bio xml:lang="en"><p>Yulia А. Pogorelova - Candidate of Sciences (Biology), Senior Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2713-8598</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Немашкалова</surname><given-names>Л. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nemashkalova</surname><given-names>L. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Людмила Анатольевна Немашкалова — научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Lyidmila A. Nemashkalova - Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">nemalit@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5686-8659</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лесовая</surname><given-names>Н. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Lesovaya</surname><given-names>N. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Наталья Сергеевна Лесовая — младший научный сотрудник лаборатории изучения патогенеза злокачественных опухолей</p><p>Ростов‑на‑Дону</p></bio><bio xml:lang="en"><p>Natalia S. Lesovaya - Junior Researcher of the Laboratory of Malignant Tumor Pathogenesis Study</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">n.chugunova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр онкологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр онкологии; Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Centre for Oncology; Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>10</month><year>2024</year></pub-date><volume>23</volume><issue>5</issue><elocation-id>89–103</elocation-id><permissions><copyright-statement>Copyright &amp;#x00A9; Франциянц Е.М., Сурикова Е.И., Каплиева И.В., Нескубина И.В., Шакарян Э.Г., Снежко А.В., Бандовкина В.А., Трепитаки Л.К., Погорелова Ю.А., Немашкалова Л.А., Лесовая Н.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Франциянц Е.М., Сурикова Е.И., Каплиева И.В., Нескубина И.В., Шакарян Э.Г., Снежко А.В., Бандовкина В.А., Трепитаки Л.К., Погорелова Ю.А., Немашкалова Л.А., Лесовая Н.С.</copyright-holder><copyright-holder xml:lang="en">Frantsiyants E.M., Surikova E.I., Kaplieva I.V., Neskubina I.V., Shakaryan E.G., Snezhko A.V., Bandovkina V.A., Trepitaki L.K., Pogorelova Y.A., Nemashkalova L.A., Lesovaya N.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.umjusmu.ru/jour/article/view/1609">https://www.umjusmu.ru/jour/article/view/1609</self-uri><abstract><p>Цель работы — изучение динамики содержания антиоксида нтных ферментов (супероксиддисмутазы 1 (СОД1), глутатионпероксидазы 1 (ГПО1) и глутатионредуктазы (ГР)) и продуктов перекисного окисления липидов (ПОЛ) (диеновых конъюгатов (ДК) и малонового диальдегида (МДА)) в селезенке и печени в латентный период роста и метастазирования экспериментальных опухолей.Материалы и методы. В экспериментах на 28 белых нелинейных крысах-самцах создана модель гематогенного метастазирования в печень путем перевивки саркомы 45 (С45) в селезенку, предварительно выведенную под кожу за 3 недели до этого. Ранее установлены характерные для модели сроки выхода опухоли в селезенке (5 недель) и визуализации метастазов в печени (7 недель) после трансплантации С45. В гомогенатах селезенки и печени методом иммуноферментного анализа определено содержание СОД1, ГПО1, ГР, МДА, биохимическим методом — содержание ДК в латентный период роста опухоли в селезенке и метастазирования ее в печень (1–2 недели после перевивки).Результаты. В указанные сроки описаны выраженные (в 1,5–5,2 раза, р &lt; 0,050–0,001) изменения уровня исследованных факторов в сравнении с показателями у интактных животных и крыс с выведенной под кожу селезенкой. Полученные результаты свидетельствовали о параллельной активизации процессов ПОЛ и защитной антиоксидантной системы в селезенке (органе-опухоленосителе) в латентный период роста и метастазирования С45. Наблюдаемые в эти же сроки изменения исследованных показателей в печени (органе-мишени метастазирования) также указывали на активацию ПОЛ, но сопровождались выраженным снижением содержания ГР (в 5 раз, р &lt; 0,001) без изменения уровня СОД1.Заключение. Результаты свидетельствуют о неполноценности антиоксидантной защиты и формировании прооксидантных условий в печени в латентный период роста опухоли, что может подготавливать почву для метастазирования.</p></abstract><trans-abstract xml:lang="en"><p>Purpose — to investigate the dynamics of the content of antioxidant enzymes superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPO1), glutathione reductase (GR) and lipid peroxidation products diene conjugates (DC), malondialdehyde (MDA) in the spleen and liver during the latent period of growth and metastasis of experimental tumor.Materials and methods. Using 28 white male rats, a model of hematogenous liver metastasis was created by transplanting sarcoma 45 cells (S45) into the spleen, previously lead out under the skin 3 weeks before. Previously, was determined that a tumor visualized in the spleen at 5 weeks, and liver metastases at 7 weeks after transplantation S45. Levels of SOD1, GPO1, GR and MDA were determined using ELISA and DC by biochemical method in spleen and liver homogenates during the latent period of tumor growth and metastasis (1–2 weeks post-transplantation).Results. Significant changes (1.5–5.2 times, р &lt; 0.050–0.001) in studied factors levels were observed compared to intact rats and rats with the spleen lead out. Activation of lipid peroxidation and antioxidant system was noted in the spleen (tumor-carrying organ) during tumor growth and metastasis. At the same time, in the liver (the target organ of metastasis) observed also increased lipid peroxidation but simultaneously a pronounced decreased GR levels (5 times, p &lt; 0.001) without affecting SOD1 levels.Conclusion. Liver tissue exhibited the inferiority of antioxidant protection and the formation of pro-oxidant condition during the latent period of tumor growth, which may prepare the soil for metastasis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>метастазирование</kwd><kwd>печень</kwd><kwd>селезенка</kwd><kwd>саркома 45</kwd><kwd>крысы</kwd><kwd>свободнорадикальное окисление</kwd><kwd>модель</kwd></kwd-group><kwd-group xml:lang="en"><kwd>metastasizing</kwd><kwd>rats</kwd><kwd>liver</kwd><kwd>spleen</kwd><kwd>sarcoma 45</kwd><kwd>free radical oxidation</kwd><kwd>model</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplieva IV, Frantsiyants EM, Kit OI. Pathogenetic aspects of metastatic liver damage (experimental study). Moskow: Kredo; 2022. 356 p. (In Russ.). EDN: https://elibrary.ru/CCLUYR.</mixed-citation><mixed-citation xml:lang="en">Kaplieva IV, Frantsiyants EM, Kit OI. Pathogenetic aspects of metastatic liver damage (experimental study). Moskow: Kredo; 2022. 356 p. (In Russ.). EDN: https://elibrary.ru/CCLUYR.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer Epidemiology. 2020;67:101760. DOI: https://doi.org/10.1016/j.canep.2020.101760.</mixed-citation><mixed-citation xml:lang="en">Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer Epidemiology. 2020;67:101760. DOI: https://doi.org/10.1016/j.canep.2020.101760.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Belova YV, Altufiev YV. Mechanisms of development of pathological processes in the liver. Natural Sciences. 2009;(3):114–120. (In Russ.). EDN: https://elibrary.ru/LHMRGV.</mixed-citation><mixed-citation xml:lang="en">Belova YV, Altufiev YV. Mechanisms of development of pathological processes in the liver. Natural Sciences. 2009;(3):114–120. (In Russ.). EDN: https://elibrary.ru/LHMRGV.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang S, Lu S, Li Z. Extrahepatic factors in hepatic immune regulation. Frontiers in Immunology. 2022;13:941721. DOI: https://doi.org/10.3389/fimmu.2022.941721.</mixed-citation><mixed-citation xml:lang="en">Zhang S, Lu S, Li Z. Extrahepatic factors in hepatic immune regulation. Frontiers in Immunology. 2022;13:941721. DOI: https://doi.org/10.3389/fimmu.2022.941721.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng M, Tian Z. Liver-mediated adaptive immune tolerance. Frontiers in Immunology. 2019;10:2525. DOI: https://doi.org/10.3389/fimmu.2019.02525.</mixed-citation><mixed-citation xml:lang="en">Zheng M, Tian Z. Liver-mediated adaptive immune tolerance. Frontiers in Immunology. 2019;10:2525. DOI: https://doi.org/10.3389/fimmu.2019.02525.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ahmed O, Robinson MW, O’Farrelly C. Inflammatory processes in the liver: Divergent roles in homeostasis and pathology. Cellular &amp; Molecular Immunology. 2021;18:1375–1386. DOI: https://doi.org/10.1038/s41423-021-00639-2.</mixed-citation><mixed-citation xml:lang="en">Ahmed O, Robinson MW, O’Farrelly C. Inflammatory processes in the liver: Divergent roles in homeostasis and pathology. Cellular &amp; Molecular Immunology. 2021;18:1375–1386. DOI: https://doi.org/10.1038/s41423-021-00639-2.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao J, Zhang X, Li Y, Yu J, Chen Z, Niu Y, et al. Interorgaо DOI: https://doi.org/10.3389/fimmu.2023.1314123.</mixed-citation><mixed-citation xml:lang="en">Zhao J, Zhang X, Li Y, Yu J, Chen Z, Niu Y, et al. Interorgaо DOI: https://doi.org/10.3389/fimmu.2023.1314123.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kelly AM, Golden-Mason L, Traynor O, Geoghegan J, McEntee G, Hegarty JE, et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: Implications for hepatic anti-tumour immunity. Cytokine. 2006;35(3–4):171–179. DOI: https://doi.org/10.1016/j.cyto.2006.07.019.</mixed-citation><mixed-citation xml:lang="en">Kelly AM, Golden-Mason L, Traynor O, Geoghegan J, McEntee G, Hegarty JE, et al. Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: Implications for hepatic anti-tumour immunity. Cytokine. 2006;35(3–4):171–179. DOI: https://doi.org/10.1016/j.cyto.2006.07.019.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology. 2008;47(2): 729–736. DOI: https://doi.org/10.1002/hep.22034.</mixed-citation><mixed-citation xml:lang="en">Gao B, Jeong WI, Tian Z. Liver: An organ with predominant innate immunity. Hepatology. 2008;47(2): 729–736. DOI: https://doi.org/10.1002/hep.22034.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in glutathione content in liver diseases: An update. Antioxidants. 2021;10(3):364. DOI: https://doi.org/10.3390/antiox10030364.</mixed-citation><mixed-citation xml:lang="en">Vairetti M, Di Pasqua LG, Cagna M, Richelmi P, Ferrigno A, Berardo C. Changes in glutathione content in liver diseases: An update. Antioxidants. 2021;10(3):364. DOI: https://doi.org/10.3390/antiox10030364.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV, Di Sabatino A. Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease. Frontiers in Medicine. 2023;10:1124275. DOI: https://doi.org/10.3389/fmed.2023.1124275.</mixed-citation><mixed-citation xml:lang="en">Santacroce G, Gentile A, Soriano S, Novelli A, Lenti MV, Di Sabatino A. Glutathione: Pharmacological aspects and implications for clinical use in non-alcoholic fatty liver disease. Frontiers in Medicine. 2023;10:1124275. DOI: https://doi.org/10.3389/fmed.2023.1124275.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Perelmuter VM, Manskikh VN. Preniche as missing link of the metastatic niche concept explaining organ- preferential metastasis of malignant tumors and the type of metastatic disease. Biochemistry. 2012; 77(1):111–118. DOI: https://doi.org/10.1134/S0006297912010142.</mixed-citation><mixed-citation xml:lang="en">Perelmuter VM, Manskikh VN. Preniche as missing link of the metastatic niche concept explaining organ- preferential metastasis of malignant tumors and the type of metastatic disease. Biochemistry. 2012; 77(1):111–118. DOI: https://doi.org/10.1134/S0006297912010142.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Akhtar M, Haider A, Rashid S, Al-Nabet ADMH. Paget’s “seed and soil” theory of cancer metastasis: An idea whose time has come. Advances In Anatomic Pathology. 2019;26(1):69–74. DOI: https://doi.org/10.1097/PAP.0000000000000219.</mixed-citation><mixed-citation xml:lang="en">Akhtar M, Haider A, Rashid S, Al-Nabet ADMH. Paget’s “seed and soil” theory of cancer metastasis: An idea whose time has come. Advances In Anatomic Pathology. 2019;26(1):69–74. DOI: https://doi.org/10.1097/PAP.0000000000000219.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Izraely S, Witz IP. Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment. International Journal of Cancer. 2021;148(6):1308–1322. DOI: https://doi.org/10.1002/ijc.33247.</mixed-citation><mixed-citation xml:lang="en">Izraely S, Witz IP. Site-specific metastasis: A cooperation between cancer cells and the metastatic microenvironment. International Journal of Cancer. 2021;148(6):1308–1322. DOI: https://doi.org/10.1002/ijc.33247.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Frantsiyants EM, Bandovkina VA, Kaplieva IV, Surikova EI, Neskubina IV, Pogorelova YuA, et al. Changes in pathophysiology of tumor growth and functional activity of the hypothalamic-pituitary-thyroid axis in rats of both sexes with the development of Guerin’s carcinoma on the background of hypothyroidism. South Russian Journal of Cancer. 2022;3(4):26–39. (In Russ.). DOI: https://doi.org/10.37748/2686-9039-2022-3-4-3.</mixed-citation><mixed-citation xml:lang="en">Frantsiyants EM, Bandovkina VA, Kaplieva IV, Surikova EI, Neskubina IV, Pogorelova YuA, et al. Changes in pathophysiology of tumor growth and functional activity of the hypothalamic-pituitary-thyroid axis in rats of both sexes with the development of Guerin’s carcinoma on the background of hypothyroidism. South Russian Journal of Cancer. 2022;3(4):26–39. (In Russ.). DOI: https://doi.org/10.37748/2686-9039-2022-3-4-3.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Frantsiyants EM, Kaplieva IV, Bandovkina VA, Surikova EI, Neskubina IV, Trepitaki LK, et al. Modeling of multiple primary malignant tumors in experiment. South Russian Journal of Cancer. 2022;3(2):14–21. (In Russ.). DOI: https://doi.org/10.37748/2686-9039-2022-3-2-2.</mixed-citation><mixed-citation xml:lang="en">Frantsiyants EM, Kaplieva IV, Bandovkina VA, Surikova EI, Neskubina IV, Trepitaki LK, et al. Modeling of multiple primary malignant tumors in experiment. South Russian Journal of Cancer. 2022;3(2):14–21. (In Russ.). DOI: https://doi.org/10.37748/2686-9039-2022-3-2-2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kit OI, Frantsiyants EM, Kaplieva IV, Trepitaki LK, Evstratova OF. A method for reproduction of metastases in the liver. Bulletin of Experimental Biology and Medicine. 2014;157(6):773–775. DOI: https://doi.org/10.1007/s10517-014-2664-0.</mixed-citation><mixed-citation xml:lang="en">Kit OI, Frantsiyants EM, Kaplieva IV, Trepitaki LK, Evstratova OF. A method for reproduction of metastases in the liver. Bulletin of Experimental Biology and Medicine. 2014;157(6):773–775. DOI: https://doi.org/10.1007/s10517-014-2664-0.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kopylova TN. A new method for the determination of conjugated dienes in blood serum. In: Majore AJa (ed.). Cellular and subcellular experimental pathology of the liver. Riga: Zinatne; 1982. P. 135. (In Russ.).</mixed-citation><mixed-citation xml:lang="en">Kopylova TN. A new method for the determination of conjugated dienes in blood serum. In: Majore AJa (ed.). Cellular and subcellular experimental pathology of the liver. Riga: Zinatne; 1982. P. 135. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Reczek CR, Chandel NS. The two faces of reactive oxygen species in cancer. Annual Review of Cancer Biology. 2017;1(1):79–98. DOI: https://doi.org/10.1146/annurev-cancerbio‑041916-065808.</mixed-citation><mixed-citation xml:lang="en">Reczek CR, Chandel NS. The two faces of reactive oxygen species in cancer. Annual Review of Cancer Biology. 2017;1(1):79–98. DOI: https://doi.org/10.1146/annurev-cancerbio‑041916-065808.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y, Branicky R, Noë A, Hekimi S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. Journal of Cell Biology. 2018;217(6):1915–1928. DOI: https://doi.org/10.1083/jcb.201708007.</mixed-citation><mixed-citation xml:lang="en">Wang Y, Branicky R, Noë A, Hekimi S. Superoxide dismutases: Dual roles in controlling ROS damage and regulating ROS signaling. Journal of Cell Biology. 2018;217(6):1915–1928. DOI: https://doi.org/10.1083/jcb.201708007.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Archives of Toxicology. 2023;97(10): 2499–2574. DOI: https://doi.org/10.1007/s00204-023-03562-9.</mixed-citation><mixed-citation xml:lang="en">Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging. Archives of Toxicology. 2023;97(10): 2499–2574. DOI: https://doi.org/10.1007/s00204-023-03562-9.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Miao L, St Clair DK. Regulation of superoxide dismutase genes: Implications in disease. Free Radical Biology and Medicine. 2009;47(4):344–356. DOI: https://doi.org/10.1016/j.freeradbiomed.2009.05.018.</mixed-citation><mixed-citation xml:lang="en">Miao L, St Clair DK. Regulation of superoxide dismutase genes: Implications in disease. Free Radical Biology and Medicine. 2009;47(4):344–356. DOI: https://doi.org/10.1016/j.freeradbiomed.2009.05.018.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. о:1323–1367. DOI: https://doi.org/10.1007/s00204-024-03696-4.</mixed-citation><mixed-citation xml:lang="en">Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. о:1323–1367. DOI: https://doi.org/10.1007/s00204-024-03696-4.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pinegin BV, Vorobjeva NV, Pashenkov MV, Chernyak BV. The role of mitochondrial reactive oxygen species in activation of innate immunity. Immunology. 2018;39(4):221–229. (In Russ.). EDN: https://elibrary.ru/tkjzta.</mixed-citation><mixed-citation xml:lang="en">Pinegin BV, Vorobjeva NV, Pashenkov MV, Chernyak BV. The role of mitochondrial reactive oxygen species in activation of innate immunity. Immunology. 2018;39(4):221–229. (In Russ.). EDN: https://elibrary.ru/tkjzta.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Chelombitko MA. The role of reactive oxygen species in inflammation. Mini-review. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2018;73(4):242–246. (In Russ.). EDN: https://elibrary.ru/ypxdhv.</mixed-citation><mixed-citation xml:lang="en">Chelombitko MA. The role of reactive oxygen species in inflammation. Mini-review. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2018;73(4):242–246. (In Russ.). EDN: https://elibrary.ru/ypxdhv.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Andrés CMC, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E. Chemistry of hydrogen peroxide formation and elimination in mammalian cells, and its role in various pathologies. Stresses. 2022;2(3):256–274. DOI: https://doi.org/10.3390/stresses2030019.</mixed-citation><mixed-citation xml:lang="en">Andrés CMC, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E. Chemistry of hydrogen peroxide formation and elimination in mammalian cells, and its role in various pathologies. Stresses. 2022;2(3):256–274. DOI: https://doi.org/10.3390/stresses2030019.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kulinsky VI, Kolesnichenko LS. The glutathione system. II. Other enzymes, thiol-disulfide metabolism, inflammation, and immunity, functions. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2009;3:211–220 (In Russ.). DOI: https://doi.org/10.1134/S1990750809030019.</mixed-citation><mixed-citation xml:lang="en">Kulinsky VI, Kolesnichenko LS. The glutathione system. II. Other enzymes, thiol-disulfide metabolism, inflammation, and immunity, functions. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2009;3:211–220 (In Russ.). DOI: https://doi.org/10.1134/S1990750809030019.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Couto N, Wood J, Barber J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radical Biology and Medicine. 2016;95:27–42. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.02.028.</mixed-citation><mixed-citation xml:lang="en">Couto N, Wood J, Barber J. The role of glutathione reductase and related enzymes on cellular redox homoeostasis network. Free Radical Biology and Medicine. 2016;95:27–42. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.02.028.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Vašková J, Kočan L, Vaško L, Perjési P. Glutathione-related enzymes and proteins: A review. Molecules. 2023;28(3):1447. DOI: https://doi.org/10.3390/molecules28031447.</mixed-citation><mixed-citation xml:lang="en">Vašková J, Kočan L, Vaško L, Perjési P. Glutathione-related enzymes and proteins: A review. Molecules. 2023;28(3):1447. DOI: https://doi.org/10.3390/molecules28031447.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Communication and Signaling. 2024;22(1):7. DOI: https://doi.org/10.1186/s12964-023-01398-5.</mixed-citation><mixed-citation xml:lang="en">Iqbal MJ, Kabeer A, Abbas Z, Siddiqui HA, Calina D, Sharifi-Rad J, et al. Interplay of oxidative stress, cellular communication and signaling pathways in cancer. Cell Communication and Signaling. 2024;22(1):7. DOI: https://doi.org/10.1186/s12964-023-01398-5.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 2015;27(2):211–222. DOI: https://doi.org/10.1016/j.ccell.2014.11.019.</mixed-citation><mixed-citation xml:lang="en">Harris IS, Treloar AE, Inoue S, Sasaki M, Gorrini C, Lee KC, et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell. 2015;27(2):211–222. DOI: https://doi.org/10.1016/j.ccell.2014.11.019.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4‑hydroxy‑2‑nonenal. Oxidative Medicine and Cellular Longevity. 2014;2014:360438. DOI: https://doi.org/10.1155/2014/360438.</mixed-citation><mixed-citation xml:lang="en">Ayala A, Muñoz MF, Argüelles S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4‑hydroxy‑2‑nonenal. Oxidative Medicine and Cellular Longevity. 2014;2014:360438. DOI: https://doi.org/10.1155/2014/360438.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Qu X, Tang Y, Hua S. Immunological approaches towards cancer and inflammation: A cross talk. Frontiers in Immunology. 2018;9:563. DOI: https://doi.org/10.3389/fimmu.2018.00563.</mixed-citation><mixed-citation xml:lang="en">Qu X, Tang Y, Hua S. Immunological approaches towards cancer and inflammation: A cross talk. Frontiers in Immunology. 2018;9:563. DOI: https://doi.org/10.3389/fimmu.2018.00563.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, et al. Clinical relevance of biomarkers of oxidative stress. Antioxidants &amp; Redox Signaling. 2015;23:1144–1170. DOI: https://doi.org/10.1089/ars.2015.6317.</mixed-citation><mixed-citation xml:lang="en">Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, et al. Clinical relevance of biomarkers of oxidative stress. Antioxidants &amp; Redox Signaling. 2015;23:1144–1170. DOI: https://doi.org/10.1089/ars.2015.6317.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Tudek B, Zdżalik-Bielecka D, Tudek A, Kosicki K, Fabisiewicz A, Speina E. Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes. Free Radical Biology and Medicine. 2017;107:77–89. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.11.043.</mixed-citation><mixed-citation xml:lang="en">Tudek B, Zdżalik-Bielecka D, Tudek A, Kosicki K, Fabisiewicz A, Speina E. Lipid peroxidation in face of DNA damage, DNA repair and other cellular processes. Free Radical Biology and Medicine. 2017;107:77–89. DOI: https://doi.org/10.1016/j.freeradbiomed.2016.11.043.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Busch CJ, Binder CJ. Malondialdehyde epitopes as mediators of sterile inflammation. Biochimica et Biophysica Acta (BBA) — Molecular and Cell Biology of Lipids. 2017;1862(4):398–406. DOI: https://doi.org/10.1016/j.bbalip.2016.06.016.</mixed-citation><mixed-citation xml:lang="en">Busch CJ, Binder CJ. Malondialdehyde epitopes as mediators of sterile inflammation. Biochimica et Biophysica Acta (BBA) — Molecular and Cell Biology of Lipids. 2017;1862(4):398–406. DOI: https://doi.org/10.1016/j.bbalip.2016.06.016.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao L, Xian M, Zhang C, Guo Q, Yi Q. Lipid peroxidation of immune cells in cancer. Frontiers in Immunology. 2024;14:1322746. DOI: https://doi.org/10.3389/fimmu.2023.1322746.</mixed-citation><mixed-citation xml:lang="en">Xiao L, Xian M, Zhang C, Guo Q, Yi Q. Lipid peroxidation of immune cells in cancer. Frontiers in Immunology. 2024;14:1322746. DOI: https://doi.org/10.3389/fimmu.2023.1322746.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Sacco R, Eggenhoffner R, Giacomelli L. Glutathione in the treatment of liver diseases: Insights from clinical practice. Minerva Gastroenterologica e Dietologica. 2016;62(4):316–324. PMID: https://pubmed.gov/27603810.</mixed-citation><mixed-citation xml:lang="en">Sacco R, Eggenhoffner R, Giacomelli L. Glutathione in the treatment of liver diseases: Insights from clinical practice. Minerva Gastroenterologica e Dietologica. 2016;62(4):316–324. PMID: https://pubmed.gov/27603810.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Rose S, Melnyk S, Trusty TA, Pavliv O, Seidel L, Li J, et al. Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Research and Treatment. 2012;2012:986519. DOI: https://doi.org/10.1155/2012/986519.</mixed-citation><mixed-citation xml:lang="en">Rose S, Melnyk S, Trusty TA, Pavliv O, Seidel L, Li J, et al. Intracellular and extracellular redox status and free radical generation in primary immune cells from children with autism. Autism Research and Treatment. 2012;2012:986519. DOI: https://doi.org/10.1155/2012/986519.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Wróblewska J, Wróblewski M, Hołyńska-Iwan I, Modrzejewska M, Nuszkiewicz J, Wróblewska W, et al. The role of glutathione in selected viral diseases. Antioxidants. 2023;12(7):1325. DOI: https://doi.org/10.3390/antiox12071325.</mixed-citation><mixed-citation xml:lang="en">Wróblewska J, Wróblewski M, Hołyńska-Iwan I, Modrzejewska M, Nuszkiewicz J, Wróblewska W, et al. The role of glutathione in selected viral diseases. Antioxidants. 2023;12(7):1325. DOI: https://doi.org/10.3390/antiox12071325.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hossain M, Kubes P. Innate immune cells orchestrate the repair of sterile injury in the liver and beyond. European Journal of Immunology. 2019;49(6):831–841. DOI: https://doi.org/10.1002/eji.201847485.</mixed-citation><mixed-citation xml:lang="en">Hossain M, Kubes P. Innate immune cells orchestrate the repair of sterile injury in the liver and beyond. European Journal of Immunology. 2019;49(6):831–841. DOI: https://doi.org/10.1002/eji.201847485.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
